Evidence map›Paper›PMID 24474471›Full record

ArticleHuman molecular genetics2014

An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis.

Derek W Morris, Richard D Pearson, Paul Cormican, Elaine M Kenny, Colm T O'Dushlaine, Louis-Philippe Lemieux Perreault, Eleni Giannoulatou, Daniela Tropea, Brion S Maher, Brandon Wormley and 48 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Human molecular genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Copy Number Variations in Neuropsychiatric Disorders.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Genetics of Schizophrenia: Ready to Translate?Current psychiatry reports · 2017
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

58 authors at 19 institutions in 7 countries.

Derek W MorrisDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
Richard D PearsonWellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Paul CormicanDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
Elaine M KennyDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
Colm T O'DushlaineBroad Institute and Center for Human Genetics Research of Massachusetts General Hospital, Boston, MA 02142, USA.
Louis-Philippe Lemieux PerreaultWellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK Montreal Heart Institute, Université de Montréal, Montréal, Québec H1T 1C8, Canada.
Eleni GiannoulatouWellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Daniela TropeaDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
Brion S MaherDepartments of Psychiatry and Human Genetics, Virginia Institute of Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23284, USA.
Brandon WormleyDepartments of Psychiatry and Human Genetics, Virginia Institute of Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23284, USA.
Eric KelleherDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
Ciara FaheyDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
Ines MolinosDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
Stefania BelliniDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
Matti PirinenWellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Amy StrangeWellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Colin FreemanWellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Dawn L ThiseltonDepartments of Psychiatry and Human Genetics, Virginia Institute of Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23284, USA.
Rachel L ElvesDepartments of Psychiatry and Human Genetics, Virginia Institute of Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23284, USA.
Regina ReganSchool of Medicine and Medical Science, University College Dublin, Ireland.
Sean EnnisSchool of Medicine and Medical Science, University College Dublin, Ireland.
Timothy G DinanDepartment of Psychiatry, University College Cork, Cork, Ireland.
Colm McDonaldDepartment of Psychiatry, National University of Ireland, Galway, University Road, Galway, Ireland.
Kieran C MurphyDepartment of Psychiatry, RCSI Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland.
Eadbhard O'CallaghanDETECT Early Intervention in Psychosis Services, Dun Laoghaire, Co. Dublin, Ireland.
John L WaddingtonMolecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Dermot WalshHealth Research Board, 73 Lower Baggot St, Dublin 2, Ireland.
Michael O'DonovanMRC Centre for Neuropsychiatric Genetics and Genomics, and Neuroscience and Mental Health Research Institute, Cardiff University, Heath Park, Cardiff CF4 4XN, UK.
Detelina GrozevaMRC Centre for Neuropsychiatric Genetics and Genomics, and Neuroscience and Mental Health Research Institute, Cardiff University, Heath Park, Cardiff CF4 4XN, UK.
Nick CraddockMRC Centre for Neuropsychiatric Genetics and Genomics, and Neuroscience and Mental Health Research Institute, Cardiff University, Heath Park, Cardiff CF4 4XN, UK.
Jennifer StoneBroad Institute and Center for Human Genetics Research of Massachusetts General Hospital, Boston, MA 02142, USA.
Ed ScolnickBroad Institute and Center for Human Genetics Research of Massachusetts General Hospital, Boston, MA 02142, USA.
Shaun PurcellBroad Institute and Center for Human Genetics Research of Massachusetts General Hospital, Boston, MA 02142, USA The Mount Sinai Hospital, New York, NY 10029, USA.
Pamela SklarBroad Institute and Center for Human Genetics Research of Massachusetts General Hospital, Boston, MA 02142, USA The Mount Sinai Hospital, New York, NY 10029, USA.
Bradley CoeUniversity of Washington School of Medicine, Howard Hughes Medical Institute, Seattle, WA 98195, USA.
Evan E EichlerUniversity of Washington School of Medicine, Howard Hughes Medical Institute, Seattle, WA 98195, USA.
Roel OphoffDepartment of Human Genetics, UCLA School of Medicine, Los Angeles, CA 90095, USA.
Jacobine BuizerRudolf Magnus Institute, University of Utrecht, 3584 CG Utrecht, Netherlands.
Jin SzatkiewiczUniversity of North Carolina, Chapel Hill, NC 27599-7264, USA.
Christina HultmanDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Patrick SullivanUniversity of North Carolina, Chapel Hill, NC 27599-7264, USA.
Hugh GurlingMolecular Psychiatry Laboratory, Mental Health Sciences Unit, University College London, London WC1E 6BT, UK.
Andrew McquillinMolecular Psychiatry Laboratory, Mental Health Sciences Unit, University College London, London WC1E 6BT, UK.
David St ClairInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.
Elliott ReesMRC Centre for Neuropsychiatric Genetics and Genomics, and Neuroscience and Mental Health Research Institute, Cardiff University, Heath Park, Cardiff CF4 4XN, UK.
George KirovMRC Centre for Neuropsychiatric Genetics and Genomics, and Neuroscience and Mental Health Research Institute, Cardiff University, Heath Park, Cardiff CF4 4XN, UK.
James WaltersMRC Centre for Neuropsychiatric Genetics and Genomics, and Neuroscience and Mental Health Research Institute, Cardiff University, Heath Park, Cardiff CF4 4XN, UK.
Douglas BlackwoodDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh EH10 5HF, UK and.
Mandy JohnstoneDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh EH10 5HF, UK and.
Gary DonohoeDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
International Schizophrenia Consortium, SGENE+ Consortium
Francis A O'NeillDepartment of Psychiatry, Queen's University, Belfast BT7 1NN, Northern Ireland.
Wellcome Trust Case Control Consortium 2
Kenneth S KendlerDepartments of Psychiatry and Human Genetics, Virginia Institute of Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23284, USA.
Michael GillDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland.
Brien P RileyDepartments of Psychiatry and Human Genetics, Virginia Institute of Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23284, USA.
Chris C A SpencerWellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Aiden CorvinDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin 2, Ireland acorvin@tcd.ie.
Trinity College Dublin · IECentre for Human Genetics · GBCardiff University · GBVirginia Commonwealth University · USBroad Institute · USHoward Hughes Medical Institute · USRoyal Edinburgh Hospital · GBUniversity College Dublin · IEUniversity College London · GBUniversity of North Carolina at Chapel Hill · USBeaumont Hospital · IEHealth Research Board · IEKarolinska Institutet · SEOllscoil na Gaillimhe – University of Galway · IERoyal College of Surgeons in Ireland · IEUniversity College Cork · IEUniversity Medical Center Utrecht · NLUniversity of Aberdeen · GBUniversity of California, Los Angeles · US

Funding

THE GENETIC EPIDEMIOLOGY OF SCHIZOPHRENIA IN IRELANDR01MH041953 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI KENDLER, KENNETH SEEDMAN · 1987 to 2008
$5.2M
A genome-wide association study of schizophrenia in IrelandR01MH083094 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI RILEY, BRIEN P · 2008 to 2011
$3.5M
Medical Research Council G0000934Medical Research Council G0601635Medical Research Council G0800509Medical Research Council G1000708Medical Research Council MR/L010305/1NIMH NIH HHS MH083094NIMH NIH HHS MH 41953NIMH NIH HHS R01 MH041953NIMH NIH HHS R01 MH083094Wellcome Trust 068545/Z/02Wellcome Trust 072894/Z/03/ZWellcome Trust 075491/Z/04/BWellcome Trust 085475/B/08/ZWellcome Trust 085475/Z/08/ZWellcome Trust 090532Wellcome Trust 090532/Z/09/ZWellcome Trust 097364/Z/11/ZWellcome Trust 100135
6 · The paper itself

Abstract

Identifying rare, highly penetrant risk mutations may be an important step in dissecting the molecular etiology of schizophrenia. We conducted a gene-based analysis of large (>100 kb), rare copy-number variants (CNVs) in the Wellcome Trust Case Control Consortium 2 (WTCCC2) schizophrenia sample of 1564 cases and 1748 controls all from Ireland, and further extended the analysis to include an additional 5196 UK controls. We found association with duplications at chr20p12.2 (P = 0.007) and evidence of replication in large independent European schizophrenia (P = 0.052) and UK bipolar disorder case-control cohorts (P = 0.047). A combined analysis of Irish/UK subjects including additional psychosis cases (schizophrenia and bipolar disorder) identified 22 carriers in 11 707 cases and 10 carriers in 21 204 controls [meta-analysis Cochran-Mantel-Haenszel P-value = 2 × 10(-4); odds ratio (OR) = 11.3, 95% CI = 3.7, ∞]. Nineteen of the 22 cases and 8 of the 10 controls carried duplications starting at 9.68 Mb with similar breakpoints across samples. By haplotype analysis and sequencing, we identified a tandem ~149 kb duplication overlapping the gene p21 Protein-Activated Kinase 7 (PAK7, also called PAK5) which was in linkage disequilibrium with local haplotypes (P = 2.5 × 10(-21)), indicative of a single ancestral duplication event. We confirmed the breakpoints in 8/8 carriers tested and found co-segregation of the duplication with illness in two additional family members of one of the affected probands. We demonstrate that PAK7 is developmentally co-expressed with another known psychosis risk gene (DISC1) suggesting a potential molecular mechanism involving aberrant synapse development and plasticity.

Indexed as

Chromosome DuplicationBipolar DisorderCase-Control StudiesChromosome BreakpointsDNA Copy Number VariationsFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansLinkage DisequilibriumMaleNerve Tissue ProteinsNeuronal Plasticityp21-Activated KinasesPsychotic DisordersSchizophreniaDISC1 protein, humanNerve Tissue Proteinsp21-Activated KinasesPAK5 protein, human

Identifiers

PMID24474471
PMCPMC4030770
OpenAlexW2150359400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.